Semaglutide Side Effects: Week by Week What to Expect

Semaglutide (Wegovy) follows a standardized dose escalation over 16-20 weeks: 0.25 mg for 4 weeks, 0.5 mg for 4 weeks, 1.0 mg for 4 weeks, 1.7 mg for 4 weeks, and finally the maintenance dose of 2.4 mg. Each increase brings a new wave of side effects that typically peaks in the first 1-2 weeks and then subsides. Understanding this pattern helps people stick with treatment through the adjustment period.

This is the introductory dose designed to acclimate your body. Many people experience mild nausea — a vague queasiness rather than intense nausea. It typically appears 1-3 hours after the weekly injection and fades within 24-48 hours.

Reduced appetite is noticeable but subtle. You may forget to eat or find yourself satisfied with smaller portions. Weight loss at this dose is minimal — 1-2 pounds over the first month is typical.

Other common experiences: mild constipation, occasional headaches, and slight fatigue for 1-2 days after injection. Some people feel almost nothing at this dose, which is normal — the therapeutic effects build with higher doses.

Tip: Eat smaller, blander meals on injection day. Avoid greasy, spicy, or heavy foods. Stay well hydrated.

The first dose increase is where most people first feel the medication working significantly. Nausea often returns or intensifies for the first 1-2 weeks at the new dose, then subsides. Appetite suppression becomes more noticeable — some people find they need to set reminders to eat.

Constipation may become more pronounced. Drinking more water, eating fiber-rich foods, and taking a magnesium supplement can help. Some people experience the opposite — diarrhea or loose stools.

Weight loss typically accelerates to 1-2 pounds per week. Energy levels may fluctuate as your body adapts to eating less. Injection site reactions (small red marks, mild itching) may appear but usually resolve within a day.

Tip: If nausea is significant, ask your doctor about staying at 0.5 mg for an extra 2-4 weeks before escalating. Faster escalation is not better — tolerance at each dose makes subsequent increases easier.

This is the dose where side effects often peak for many users. Nausea can be more persistent — lasting 2-3 days after injection rather than just 24 hours. The key distinction: if nausea is manageable (you can eat and function), continue. If it is severe (unable to keep food down), contact your prescriber about slowing escalation.

Gastrointestinal effects broaden: acid reflux, bloating, and gas are common. These occur because Semaglutide slows gastric emptying — food sits in your stomach longer. Eating smaller meals more frequently (4-5 small meals vs 2-3 large ones) significantly helps.

Weight loss continues at 1-2+ pounds per week. Many users report that food preferences shift — fatty or sugary foods become less appealing or even aversive. This is a known neurological effect of GLP-1 receptor activation on reward pathways.

Some users report increased fatigue or brain fog during the first week at 1.0 mg. This typically resolves as the body adjusts.

By this stage, most users have adapted to the gastrointestinal effects and the final dose increases are better tolerated than earlier ones. The body has had 12+ weeks to adjust to GLP-1 receptor activation.

Side effects at 1.7 mg and 2.4 mg are similar in character to 1.0 mg but may briefly intensify for a few days after each increase. The most common new complaint at higher doses is more pronounced constipation, which may require a stool softener or increased fiber.

Weight loss is strongest at 1.7-2.4 mg. Most of the total weight loss occurs during the first 6-12 months at maintenance dose. After that, weight loss slows and stabilizes — the medication maintains the lower weight rather than causing continued loss.

Rare but important: watch for signs of pancreatitis (severe upper abdominal pain radiating to the back, with vomiting) and gallstones (right-sided abdominal pain after eating fatty foods). Both are uncommon but are associated with rapid weight loss and GLP-1 therapy.

After 6 months, most gastrointestinal side effects have either resolved or become manageable. Common long-term experiences include:

Stable appetite suppression — eating less feels normal rather than forced. Most users report eating 30-50% less than their pre-treatment intake without discomfort.

Mild ongoing constipation is the most persistent long-term side effect. A daily fiber supplement and adequate hydration are often sufficient.

Weight plateau typically occurs at 12-18 months. This is expected — the body reaches a new set point. If weight begins to rebound while still on medication, dietary habits rather than medication failure are usually the cause.

Hair thinning or shedding (telogen effluvium) can occur 3-6 months after significant weight loss. This is caused by the caloric deficit and rapid weight change, not the medication directly. It is temporary and resolves as weight stabilizes.

Discuss any persistent or worsening side effects with your prescribing physician. Dose adjustments (stepping down from 2.4 mg to 1.7 mg) are appropriate when side effects outweigh benefits at the maximum dose.